Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial Design
Launched by BOEHRINGER INGELHEIM · Nov 24, 2008
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Patients with type 2 diabetes (drug naive or pre-treated) with insufficient glycaemic control (HbA1c higher or equal than 7.5 to less than 11.0 %), with very poor glycaemic control (HbA1c higher or equal than 11.0 %) who are not eligible for randomisation to be included in the open-label arm
- Exclusion criteria:
- • Myocardial infarction, stroke or transient ischemic attack (TIA), unstable or acute congestive heart failure, impaired hepatic function, treatment with rosiglitazone or pioglitazone, with a GLP1 analogue, with insulin, with anti-obesity drugs, with systemic steroids, renal failure or impairment, gastric bypass
About Boehringer Ingelheim
Boehringer Ingelheim is a global, research-driven pharmaceutical company dedicated to improving health and quality of life through innovative therapies. Established in 1885 and headquartered in Ingelheim, Germany, the company focuses on the development of prescription medicines in key therapeutic areas, including respiratory diseases, cardiovascular health, oncology, and immunology. Boehringer Ingelheim is committed to advancing medical science through rigorous clinical trials and collaborative research, striving to bring novel treatments to patients while upholding the highest standards of safety and efficacy. With a strong emphasis on sustainability and corporate responsibility, the company aims to make a meaningful impact on global health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Calgary, Alberta, Canada
Edmonton, Alberta, Canada
Red Deer, Alberta, Canada
Vancouver, British Columbia, Canada
Winnipeg, Manitoba, Canada
Hamilton, Ontario, Canada
Oakville, Ontario, Canada
Oshawa, Ontario, Canada
Toronto, Ontario, Canada
Karlovac, , Croatia
Krapinske Toplice, , Croatia
Osijek, , Croatia
Rijeka, , Croatia
Sisak, , Croatia
Zagreb, , Croatia
Pärnu, , Estonia
Tallin, , Estonia
Tallin, , Estonia
Aire Sur L'aadour, , France
Bischheim, , France
Bourges, , France
Bousse, , France
Carresse Cassaber, , France
Gambsheim, , France
Garchizy, , France
Grenoble Cédex, , France
Guerigny, , France
Jarny, , France
La Riche, , France
La Seyne Sur Mer, , France
La Seyne Sur Mer, , France
Lury, , France
Mars La Tour, , France
Mondelange, , France
Mont De Marsan, , France
Mont De Marsan, , France
Mont De Marsan, , France
Moutiers, , France
Mundolsheim, , France
Nevers, , France
Nevers, , France
Ortez, , France
Orthez, , France
Orthez, , France
Orthez, , France
Pont à Mousson, , France
Saint Avertin, , France
Saint Avertin, , France
Salies De Bearn, , France
Savonnières, , France
St Martin D'oney, , France
Strasbourg, , France
Strasbourg, , France
Strasbourg, , France
Toulon, , France
Toulon, , France
Toulon, , France
Tours, , France
Vandoeuvre Les Nancy, , France
Bad Dürrheim Sunthausen, , Germany
Bad Mergentheim, , Germany
Köln, , Germany
München, , Germany
Neuwied, , Germany
Schauenburg, , Germany
Aurangabad, , India
Babgalore, , India
Bangalore, , India
Bangalore, , India
Bangalore, , India
Bhopal, , India
Chennai, , India
Chennai, , India
Hyderadad, , India
Jaipur, , India
Madurai, , India
Maharashtra, , India
Manipal, , India
Mumbai, , India
Nagpur, , India
New Delhi, , India
P.O Trivandrum, , India
Pune, , India
West Bengal, , India
Kaunas, , Lithuania
Kaunas, , Lithuania
Vilnius, , Lithuania
Aguascalientes, , Mexico
Cuernavaca, , Mexico
Guadalajara, , Mexico
Guadalajara, , Mexico
Mexico, , Mexico
Mexico, , Mexico
Pachuca, , Mexico
Tijuana, , Mexico
Veracruz, , Mexico
'S Hertogenbosch, , Netherlands
'S Hertogenbosch, , Netherlands
Almere, , Netherlands
Beek En Donk, , Netherlands
Beek, , Netherlands
Breda, , Netherlands
Eindhoven, , Netherlands
Groningen, , Netherlands
Leiderdrop, , Netherlands
Nijmegen, , Netherlands
Rotterdam, , Netherlands
Velp, , Netherlands
Zoetermeer, , Netherlands
Alba Iulia, , Romania
Galati, , Romania
Oradea, , Romania
Ploiesti, , Romania
Satu Mare, , Romania
Moscow, , Russian Federation
Moscow, , Russian Federation
Moscow, , Russian Federation
Moscow, , Russian Federation
Moscow, , Russian Federation
Moscow, , Russian Federation
St. Petersburg, , Russian Federation
St. Petersburg, , Russian Federation
Goteborg, , Sweden
Goteborg, , Sweden
Malmo, , Sweden
Stockholm, , Sweden
Uppsala, , Sweden
Bab Sâadoun Tunis, , Tunisia
Tunis, , Tunisia
Tunis, , Tunisia
Tunis, , Tunisia
Tunis, , Tunisia
Kiev, , Ukraine
Lviv, , Ukraine
Lvov, , Ukraine
Odesa, , Ukraine
Odessa, , Ukraine
Vinnitsa, , Ukraine
Patients applied
Trial Officials
Boehringer Ingelheim
Study Chair
Boehringer Ingelheim
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials